Developer docs
API playgroundTry for free, no card

Search company profiles

Semdor Pharma Group

Full company profile

uuid000zurx

Namestring
Semdor Pharma Group
Legal namestring
Semdor Pharma Group GmbH
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Semdor Pharma Group GmbH is a privately held German pharmaceutical group headquartered in Cologne that operates as Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group consolidates five wholly-owned subsidiaries — Cannamedical Pharma GmbH (medical cannabis import from Canada, Australia, and the Netherlands), PS Pharma GmbH (specialist logistics, serialization, primary packaging, and cold-chain distribution for narcotics and pharmaceuticals), PB Pharma (BfArM-authorized import and marketing of EU pharmaceuticals in Germany, including the Painbreak and Cyclocaps product lines and 500+ preparations), Cannalivery (a direct-to-patient online pharmacy for medical cannabis), and Bloombase (a digital infrastructure platform unifying telemedicine, prescription workflows, and pharmacy inventory management) — under a single corporate umbrella. Founded by David Henn in 2016 through Cannamedical and expanded into a group structure by 2021, the business serves European wholesalers, suppliers, pharmacies, and clinical facilities with narcotics and medical cannabis products.

The group monetizes through transaction-based pharmaceutical import and wholesale distribution, specialist logistics and serialization services for narcotics, BfArM-authorized parallel imports priced below domestic originals, and direct-to-patient online pharmacy sales of medical cannabis. Proprietary technical assets include a radio wave treatment process for microbiological reduction on cannabis flowers (an alternative to gamma irradiation) and the Bloombase digital platform, which the group positions as an integrated alternative to fragmented prescription and inventory tools. Operations are carried out under GDP and GMP certifications, with cold-chain pharmaceutical distribution and EU-GMP white-label cannabis products forming part of the 2022 service expansion. Group-wide revenue, funding history, and detailed ownership are not publicly disclosed; David Henn serves as authorized representative (Geschäftsführer).

Short descriptiontext

Semdor Pharma Group is a privately held German pharmaceutical group operating Cannamedical, PS Pharma, PB Pharma, Cannalivery, and Bloombase to import, manufacture, distribute, and digitally orchestrate narcotics and medical cannabis products for European wholesalers, pharmacies, clinical facilities, and patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKöln, Germany
HQ citystring
Köln
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, medical cannabis products, narcotics logistics, pharmaceutical manufacturing, online pharmacy services
Industry5 codes
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAIAJAN
Controlled Substances & Compliance-Focused Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
NAICS code4 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
  • Pharmacies and Drug Retailers456110
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Cannabis Import and Distribution
TypeTransaction Fee
Description

Cannamedical Pharma imports high-quality medical cannabis products from Canada, Australia, and the Netherlands, distributing to pharmacies and clinical facilities. This is the core revenue driver for the group.

semdor-group.com
2Narcotics and Pharmaceutical Logistics
TypeTransaction Fee
Description

PS Pharma Group provides specialist logistics services including storage, import/export, order picking, shipping, repackaging, and serialization of narcotics and pharmaceuticals under the Narcotics Act.

semdor-group.com
3EU Pharmaceutical Imports
TypeTransaction Fee
Description

PB Pharma imports and markets original pharmaceutical products from EU countries for the German market, authorized through BfArM. Offers products at lower prices than domestic originals.

semdor-group.com
4Online Pharmacy - Cannalivery
TypeTransaction Fee
Description

Direct-to-patient online pharmacy specializing in medicinal cannabis delivery, providing patients with easy and fast access to medical cannabis products.

semdor-group.com
5White-Label Cannabis Products
TypeLicensing Royalties
Description

PS Pharma Group offers exclusive EU-GMP certified white-label cannabis products on the European market.

semdor-group.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Cannamedical
Description

Medical cannabis brand importing products from Canada, Australia, and Netherlands

semdor-group.com
+4 more records
Core offering1 text field

Semdor Pharma Group is a German-based full-service pharmaceutical company specializing in narcotics and medical cannabis. Through its subsidiaries (Cannamedical Pharma, PS Pharma, PB Pharma, Cannalivery, and Bloombase), the group imports, manufactures, packages, distributes, and markets narcotics, medical cannabis, and other pharmaceuticals to European wholesalers, pharmacies, clinical facilities, and directly to patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Highest possible product standards ensured through quality management system
+2 more records
Product overview1 text field

Semdor Pharma Group is Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group comprises five main subsidiaries: Cannamedical Pharma (medical cannabis import from Canada, Australia, Netherlands), Cannalivery (online medical cannabis pharmacy), PS Pharma (specialist narcotics logistics, serialization, packaging, cold-chain distribution), PB Pharma (narcotics marketing with Painbreak and Cyclocaps product lines), and Bloombase (digital platform unifying telemedicine, prescription workflows, and pharmacy inventory management). The group offers the broadest range of narcotics and medical cannabis to European wholesalers, suppliers, and pharmacies.

Product and service7 records
1Cannamedical Pharma
CategoryMedical Cannabis Distribution
Description

Import and distribution of high-quality medical cannabis products from Canada, Australia, and the Netherlands to pharmacies and clinical facilities across Europe.

2Cannalivery
CategoryOnline Pharmacy
Description

Specialized online pharmacy delivering medicinal cannabis directly to patients, providing simple and fast access to high-quality medical cannabis products.

3PS Pharma Logistics Services
CategoryPharmaceutical Logistics
Description

Specialist logistics provider for narcotics and pharmaceuticals offering storage, import/export, order picking, shipping, serialization, primary packaging of cannabis flowers, filling of cannabis extracts and oils, and cold-chain pharmaceutical distribution.

4PB Pharma Pharmaceutical Products
CategoryPharmaceutical Marketing
Description

Pharmaceutical marketing company specializing in narcotics with over 20 years of experience marketing imported EU pharmaceutical products (including own Painbreak and Cyclocaps lines) for the German market under BfArM authorization.

5Bloombase Digital Platform
CategoryDigital Health Platform
Description

Digital backbone infrastructure platform for the medical cannabis market that unifies telemedicine, prescription workflows, and pharmacy inventory management in one integrated system from medical consultation through prescription routing to batch and inventory management.

6Painbreak
CategoryPharmaceutical Product Line
Description

PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.

7Cyclocaps
CategoryPharmaceutical Product Line
Description

PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Neuraxpharm
TypeDirect peer
Description

European specialty pharmaceutical company (HQ Germany) focused on CNS and specialty products, with narcotics/specialty pharmacy distribution capabilities. Compares to PB Pharma in EU-imported pharmaceutical marketing and BfArM-authorized distribution.

TypeDirect peer
Description

German medical cannabis producer and distributor with BfArM authorization, importing and distributing cannabis flower to German pharmacies. Direct competitor to Cannamedical with similar pharmaceutical-grade positioning, but without Semdor's parallel narcotics logistics and EU pharma import arms.

TypeDirect peer
Description

German medical cannabis importer/distributor serving pharmacies with similar BfArM-authorized cannabis imports. Competes with Cannamedical on product range, supplier relationships (Canadian/Australian), and pharmacy service levels in the same end market.

TypeDirect peer
Description

German specialty pharmaceutical distributor focused on compounded and specialty medications (including narcotics) serving pharmacies. Operates in similar downstream pharmacy channel as Semdor's PB Pharma/PS Pharma, with comparable regulatory intensity.

5Pohl-Boskamp
TypeDirect peer
Description

German specialty pharmaceutical company with established narcotics/BtM expertise and marketed products in pain and respiratory. Highly comparable to PS Pharma and PB Pharma in BtM positioning and German pharmacy channel relationships.

TypeBroad incumbent
Description

Large German specialty/generics pharma group with growing medical cannabis activities and broad European wholesale distribution. Broader portfolio than Semdor, but a competitor on EU-imported generics (vs PB Pharma) and on cannabis (vs Cannamedical).

TypeBroad incumbent
Description

Global cannabis company with European medical cannabis operations (Spectrum Therapeutics) supplying pharmacies. Competes with Cannamedical on imported flower and brand positioning, but at much broader global scale.

8Tilray Brands
TypeBroad incumbent
Description

Global cannabis operator with German distribution via Tilray Medical and a sizable European pharmaceutical/cannabis footprint. Competes with Semdor on the import and wholesale side, but is a broad incumbent rather than a narcotics/specialist niche player.

TypeOthers
Description

European pharmaceutical CDMO/manufacturer offering serialization, packaging, and cold-chain capabilities that partially overlap with PS Pharma's narcotics logistics and packaging services. More of an enabling/adjacent player than direct competitor in the medical cannabis vertical.

TypeEmerging player
Description

Global generics manufacturer with EU product imports and selective specialty pharmacy positioning relevant to PB Pharma's EU-import-authorized model. Less directly competitive in narcotics and cannabis, but exercises similar import-margin arbitrage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Semdor Pharma Group

Specialty Pharmaceuticalssemdor-group.com

Semdor Pharma Group is a privately held German pharmaceutical group operating Cannamedical, PS Pharma, PB Pharma, Cannalivery, and Bloombase to import, manufacture, distribute, and digitally orchestrate narcotics and medical cannabis products for European wholesalers, pharmacies, clinical facilities, and patients.

What Semdor Pharma Group does

Semdor Pharma Group GmbH is a privately held German pharmaceutical group headquartered in Cologne that operates as Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group consolidates five wholly-owned subsidiaries — Cannamedical Pharma GmbH (medical cannabis import from Canada, Australia, and the Netherlands), PS Pharma GmbH (specialist logistics, serialization, primary packaging, and cold-chain distribution for narcotics and pharmaceuticals), PB Pharma (BfArM-authorized import and marketing of EU pharmaceuticals in Germany, including the Painbreak and Cyclocaps product lines and 500+ preparations), Cannalivery (a direct-to-patient online pharmacy for medical cannabis), and Bloombase (a digital infrastructure platform unifying telemedicine, prescription workflows, and pharmacy inventory management) — under a single corporate umbrella. Founded by David Henn in 2016 through Cannamedical and expanded into a group structure by 2021, the business serves European wholesalers, suppliers, pharmacies, and clinical facilities with narcotics and medical cannabis products.

The group monetizes through transaction-based pharmaceutical import and wholesale distribution, specialist logistics and serialization services for narcotics, BfArM-authorized parallel imports priced below domestic originals, and direct-to-patient online pharmacy sales of medical cannabis. Proprietary technical assets include a radio wave treatment process for microbiological reduction on cannabis flowers (an alternative to gamma irradiation) and the Bloombase digital platform, which the group positions as an integrated alternative to fragmented prescription and inventory tools. Operations are carried out under GDP and GMP certifications, with cold-chain pharmaceutical distribution and EU-GMP white-label cannabis products forming part of the 2022 service expansion. Group-wide revenue, funding history, and detailed ownership are not publicly disclosed; David Henn serves as authorized representative (Geschäftsführer).

Semdor Pharma Group firmographics

Firmographics
Name
Semdor Pharma Group
Legal name
Semdor Pharma Group GmbH
Website
https://semdor-group.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Semdor Pharma Group is a privately held German pharmaceutical group operating Cannamedical, PS Pharma, PB Pharma, Cannalivery, and Bloombase to import, manufacture, distribute, and digitally orchestrate narcotics and medical cannabis products for European wholesalers, pharmacies, clinical facilities, and patients.
Ownership category
akta.pro rank

Semdor Pharma Group industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmacies and Drug Retailers (456110)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAIAJAN
Controlled Substances & Compliance-Focused Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)

Keywords

  • Pharmaceutical distribution
  • Medical cannabis products
  • Narcotics logistics
  • Pharmaceutical manufacturing
  • Online pharmacy services

Where Semdor Pharma Group is headquartered

Location

Headquarters

HQ city
Köln
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Semdor Pharma Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Cannabis Import and Distribution: Cannamedical Pharma imports high-quality medical cannabis products from Canada, Australia, and the Netherlands, distributing to pharmacies and clinical facilities. This is the core revenue driver for the group.
  2. Narcotics and Pharmaceutical Logistics: PS Pharma Group provides specialist logistics services including storage, import/export, order picking, shipping, repackaging, and serialization of narcotics and pharmaceuticals under the Narcotics Act.
  3. EU Pharmaceutical Imports: PB Pharma imports and markets original pharmaceutical products from EU countries for the German market, authorized through BfArM. Offers products at lower prices than domestic originals.
  4. Online Pharmacy - Cannalivery: Direct-to-patient online pharmacy specializing in medicinal cannabis delivery, providing patients with easy and fast access to medical cannabis products.
  5. White-Label Cannabis Products: PS Pharma Group offers exclusive EU-GMP certified white-label cannabis products on the European market.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Semdor Pharma Group product offering

Product offering

Core offering

Semdor Pharma Group is a German-based full-service pharmaceutical company specializing in narcotics and medical cannabis. Through its subsidiaries (Cannamedical Pharma, PS Pharma, PB Pharma, Cannalivery, and Bloombase), the group imports, manufactures, packages, distributes, and markets narcotics, medical cannabis, and other pharmaceuticals to European wholesalers, pharmacies, clinical facilities, and directly to patients.

Product overview

Semdor Pharma Group is Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group comprises five main subsidiaries: Cannamedical Pharma (medical cannabis import from Canada, Australia, Netherlands), Cannalivery (online medical cannabis pharmacy), PS Pharma (specialist narcotics logistics, serialization, packaging, cold-chain distribution), PB Pharma (narcotics marketing with Painbreak and Cyclocaps product lines), and Bloombase (digital platform unifying telemedicine, prescription workflows, and pharmacy inventory management). The group offers the broadest range of narcotics and medical cannabis to European wholesalers, suppliers, and pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

  • Cannamedical: Medical cannabis brand importing products from Canada, Australia, and Netherlands
  • Cannalivery
  • PS Pharma
  • PB Pharma
  • bloombase

Products and services

  • Cannamedical Pharma Import and distribution of high-quality medical cannabis products from Canada, Australia, and the Netherlands to pharmacies and clinical facilities across Europe.
  • Cannalivery Specialized online pharmacy delivering medicinal cannabis directly to patients, providing simple and fast access to high-quality medical cannabis products.
  • PS Pharma Logistics Services Specialist logistics provider for narcotics and pharmaceuticals offering storage, import/export, order picking, shipping, serialization, primary packaging of cannabis flowers, filling of cannabis extracts and oils, and cold-chain pharmaceutical distribution.
  • PB Pharma Pharmaceutical Products Pharmaceutical marketing company specializing in narcotics with over 20 years of experience marketing imported EU pharmaceutical products (including own Painbreak and Cyclocaps lines) for the German market under BfArM authorization.
  • Bloombase Digital Platform Digital backbone infrastructure platform for the medical cannabis market that unifies telemedicine, prescription workflows, and pharmacy inventory management in one integrated system from medical consultation through prescription routing to batch and inventory management.
  • Painbreak PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.
  • Cyclocaps PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.

Quantifiable outcome

  • Highest possible product standards ensured through quality management system
  • +2 more outcomes

Companies that use Semdor Pharma Group

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Semdor Pharma Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Semdor Pharma Group partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Semdor Pharma Group competitors and assessment

Company assessment

Direct peers

  • Neuraxpharm: European specialty pharmaceutical company (HQ Germany) focused on CNS and specialty products, with narcotics/specialty pharmacy distribution capabilities. Compares to PB Pharma in EU-imported pharmaceutical marketing and BfArM-authorized distribution.
  • Demecan: German medical cannabis producer and distributor with BfArM authorization, importing and distributing cannabis flower to German pharmacies. Direct competitor to Cannamedical with similar pharmaceutical-grade positioning, but without Semdor's parallel narcotics logistics and EU pharma import arms.
  • Cansativa: German medical cannabis importer/distributor serving pharmacies with similar BfArM-authorized cannabis imports. Competes with Cannamedical on product range, supplier relationships (Canadian/Australian), and pharmacy service levels in the same end market.
  • Medios AG: German specialty pharmaceutical distributor focused on compounded and specialty medications (including narcotics) serving pharmacies. Operates in similar downstream pharmacy channel as Semdor's PB Pharma/PS Pharma, with comparable regulatory intensity.
  • Pohl-Boskamp: German specialty pharmaceutical company with established narcotics/BtM expertise and marketed products in pain and respiratory. Highly comparable to PS Pharma and PB Pharma in BtM positioning and German pharmacy channel relationships.

Broad incumbents

  • STADA Arzneimittel: Large German specialty/generics pharma group with growing medical cannabis activities and broad European wholesale distribution. Broader portfolio than Semdor, but a competitor on EU-imported generics (vs PB Pharma) and on cannabis (vs Cannamedical).
  • Canopy Growth Corporation (Canopy Medical): Global cannabis company with European medical cannabis operations (Spectrum Therapeutics) supplying pharmacies. Competes with Cannamedical on imported flower and brand positioning, but at much broader global scale.
  • Tilray Brands: Global cannabis operator with German distribution via Tilray Medical and a sizable European pharmaceutical/cannabis footprint. Competes with Semdor on the import and wholesale side, but is a broad incumbent rather than a narcotics/specialist niche player.

Others

  • Aenova Group: European pharmaceutical CDMO/manufacturer offering serialization, packaging, and cold-chain capabilities that partially overlap with PS Pharma's narcotics logistics and packaging services. More of an enabling/adjacent player than direct competitor in the medical cannabis vertical.

Emerging players

  • Dr. Reddy's Laboratories (European business): Global generics manufacturer with EU product imports and selective specialty pharmacy positioning relevant to PB Pharma's EU-import-authorized model. Less directly competitive in narcotics and cannabis, but exercises similar import-margin arbitrage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Semdor Pharma Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Semdor Pharma Group leadership team

Management profile

Number of profiles

Profiles3 records

Semdor Pharma Group subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Semdor Pharma Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Semdor Pharma Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Semdor Pharma Group

What does Semdor Pharma Group do?

Semdor Pharma Group is a German-based full-service pharmaceutical company specializing in narcotics and medical cannabis. Through its subsidiaries (Cannamedical Pharma, PS Pharma, PB Pharma, Cannalivery, and Bloombase), the group imports, manufactures, packages, distributes, and markets narcotics, medical cannabis, and other pharmaceuticals to European wholesalers, pharmacies, clinical facilities, and directly to patients.

Is Semdor Pharma Group a public or private company?

Semdor Pharma Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Semdor Pharma Group founded?

Semdor Pharma Group was founded in 2016. It employs 11 to 50 people.

Where is Semdor Pharma Group based?

Semdor Pharma Group is headquartered in Köln, Germany, in the Europe region.

How does Semdor Pharma Group make money?

Five revenue lines are on record. Medical Cannabis Import and Distribution is the primary driver. The others are narcotics and Pharmaceutical Logistics, EU Pharmaceutical Imports, online Pharmacy - Cannalivery and white-Label Cannabis Products.

Who are Semdor Pharma Group's main competitors?

Direct peers on record are Neuraxpharm, Demecan, Cansativa, Medios AG and Pohl-Boskamp. Broad incumbents are STADA Arzneimittel, Canopy Growth Corporation (Canopy Medical) and Tilray Brands. Aenova Group is listed as an others. Dr. Reddy's Laboratories (European business) is listed as an emerging player.

Does Semdor Pharma Group have an API?

No public API is recorded for Semdor Pharma Group.

What industry is Semdor Pharma Group in?

Semdor Pharma Group's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of HLAIAJAN, Controlled Substances & Compliance-Focused Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales